1. Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill
2. Patient and Partners LLC, Madison, Connecticut
3. Patient-Reported Outcome Consortium, Critical Path Institute, Tucson, Arizona
4. Novartis Pharmaceuticals, East Hanover, New Jersey
5. Study Endpoints Team, Study Endpoints and Labeling Development, Office of New Drugs, Immediate Office, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland
6. Office of Hematology and Oncology Products, Office of New Drugs, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland